Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This study assesses the aerosol delivery characteristics (measured by nebulization time, serum and sputum tobramycin pharmacokinetic parameters) and safety of tobramycin administered for inhalation by PARI eFlow rapid electronic nebulizer (no compressor) vs. PARI LC PLUS Jet Nebulizer (with compressor) in subjects with cystic fibrosis.
Epistemonikos ID: 4c0b4655a18df6837b1416c2994a93687b81e3f1
First added on: May 04, 2024